Navigation Links
Minnesota partnership advances potential MS therapy
Date:4/17/2008

ROCHESTER/MINNEAPOLIS, Minn. A production laboratory founded by the Minnesota Partnership has transferred its first potential therapy a medication for multiple sclerosis to a processing plant in Minnesota. This step will complete purification of material to fully enable translation from preclinical to clinical development.

The antibody known as rHIgM22, developed at Mayo Clinic, was produced and purified in the Biotherapeutic Protein Production Laboratory created by a Partnership infrastructure award in 2006. This laboratory was developed within the Molecular and Cellular Therapeutics Facility on the St. Paul campus of the University of Minnesota. The therapy is under license to Acorda Therapeutics, Inc. (NASDAQ: ACOR), which is supporting the development of this potential therapy. This includes the Minnesota Partnerships transfer of remaining production and purification to Biovest, Inc., in Minneapolis.

The preclinical success and the promise of this program to date have only enhanced our commitment to the continued advancement of this potential new therapy for people with multiple sclerosis, says Ron Cohen, M.D., Acorda president and CEO. The Partnership has provided a mechanism for academic and commercial institutions to work together effectively in the early stages of developing a promising and innovative therapeutic approach to a very challenging condition.

The importance of the antibody as a promoter of myelin repair (remyelination) was recognized in studies using experimental animal models of multiple sclerosis. The studies were directed by Moses Rodriguez, M.D., a Mayo Clinic neurologist. Multiple sclerosis is a progressive disease, caused by damage to the myelin sheath that surrounds nerves. It can affect the brain and the spinal cord, leaving patients permanently disabled. The rHIgM22 antibody initiates the re-growth or repair of the damaged myelin sheath but has yet to be tested in patients.

The initial synthe
'/>"/>

Contact: Nick Hanson
hans2853@umn.edu
612-624-2449
University of Minnesota
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Securians Minnesota Life Continues to Climb Group Life Rankings
2. Fresh Air Campaign to Showcase Minnesotans Love of Smoke-Free Air
3. Four Minnesota Hospitals Rate High For Patient Safety and Quality
4. First-in-the-Nation Health Care Billing Policy Announced in Minnesota
5. Help is Available for Smokers Who Want to Quit as Minnesotas Smoke-Free Law Takes Effect Oct. 1
6. Maryland, Minnesota Go Smoke-free Oct. 1 - Pennsylvania Overdue in Following Suit
7. New National Medicaid Study: Minnesota Under Funds Seniors Nursing Home Care $167 Million Annually
8. Blue Cross and Partners to Host Combat Stress Conference for Minnesotas Health Care Professionals
9. TV Documentary Examines Three Decades of Tobacco Politics, Policies and People in Minnesota
10. Minneapolis Hosts National Conference on Tobacco or Health October 24-26 on Heels of Minnesotas Statewide, Smoke-Free Law
11. Mayo Clinic Calls for Thorough Review of Canadian Pacifics Acquisition of the Dakota, Minnesota & Eastern Railroad

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...dings has announced that it has become a national ...rgest nonprofit organizations dedicated to arthrit... Delray Beach, FL (Vocus) Novembe...), a company specializing in the marketing and ret...has announced today that is has become a national ...
(Date:11/27/2009)...edical, economic burdens, study predicts , ...r of people with diabetes in the United States is ...tudy predicts. , That would bring the total by ..., up from 23.7 million today. , , At the same ti... triple, the study also warns, rising from an esti...
(Date:11/27/2009)...h™ announced today that Spectrum Health (Gra...terprise orthopedic templating solution and its Tr... (PRWEB) November 27, 2009 -- Voyant Hea...rand Rapids, Michigan) has licensed its TraumaCad ...TraumaCad Extend workflow solution, to allow its o...
(Date:11/27/2009)...anufacturers who use medical load cells at the hea...s by bringing in technology partner Flintec early ...ctive medical manufacturers are calling in Flintec...rojects, ensuring that progress will not be constr...outdated technology. , (P...
(Date:11/26/2009)...ire/ -- With cold and flu season upon us, it,s mor...control the spread of infections and avoid illness...ourselves healthy, but to avoid transmitting illne...C (certified in infection-control), nursing direct...t Hospital for Special Surgery (HSS) in Manhattan....
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4
... BRUSSELS and LA GAUDE, France, May 13 IBM (NYSE:...lobal Healthcare Centre of Excellence located in L...com.com/cgi-bin/prnh/20090416/IBMLOGO ) , , Ex...utions that improve care delivery, predict and pre...
... Surgeon receives top score in Carolinas Medical C...13 Dr. Peter J. Capizzi of Stillwater Plastic Sur...he 2008 Carolinas Medical Center-University patien...es the program and selects the honorees. "The pati...
...n U.S., 40 percent of new moms aren,t married, CDC...ay News) -- The number of unmarried women having c... several other countries, according to U.S. health...ng to a report, Changing Patterns of Nonmarital C...
... HOUSTON (May 13, 2009) The beta-carotene in so...ans, according to researchers at Baylor College of... article that appears in the current issue of the ... of creating rice that had beta-carotene -- a vita...
... CEP America,s Longest-Standing Client Congratulat...ious Designation , , EMERYVILLE, Calif., May 13...rs of emergency department (ED) management and sta...entialing Center (ANCC). Only five percent of U.S....
... Voters willing to engage in discussion about trad...nt answers to tough questions about the trade-offs...data released today by the Stanford Center on Long...ds of politics, academia and the public. , , "As ...
Other Medicine News:Health News:IBM Establishes Global Healthcare Centre of Excellence in La Gaude, France 2Health News:IBM Establishes Global Healthcare Centre of Excellence in La Gaude, France 3Health News:Dr. Peter J. Capizzi of Stillwater Plastic Surgery Honored in Patient Satisfaction Survey 2Health News:More Single Women Are Having Babies 2Health News:More Single Women Are Having Babies 3Health News:More Single Women Are Having Babies 4Health News:Palomar Pomerado Health System Achieves National Recognition for Nursing Excellence by the American Nurses Credentialing Center 2Health News:Palomar Pomerado Health System Achieves National Recognition for Nursing Excellence by the American Nurses Credentialing Center 3Health News:Stanford Center on Longevity Releases New Findings About Voter Attitudes on Health Care Reform 2
(Date:11/25/2009)..., , NEW YORK, Nov. 25 /PRNewswire/ -...earch report is available in its catalogue: ,, ...www.reportlinker.com/p0164220/Pain-Management---Gl... generic drugs, emergence of pain management clini...he pace of growth in the pain management market. H...
(Date:11/25/2009)..., , DELFT, The Netherlands and JOHA...maceuticals, service division and Pyxis Discovery ...ive agreement to jointly market both,companies, se...al chemistry and lead discovery expertise,will be ... medicinal and,synthetic chemistry support to proj...
(Date:11/25/2009)..., , MOUNTAIN VIEW, Calif., Nov. 25 /PRNewsw... Phase II/III clinical data from the Company,s PRO...aluation in Crohn,s disease Trial) of Traficet-EN(... Crohn,s disease demonstrated clinical efficacy wi...he study demonstrated evidence of clinical efficac...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Elseviers PharmaPendium introduces the FDA Classic Collection 47610 1Elseviers PharmaPendium introduces the FDA Classic Collection 47610 2SRI International announces findings from new upper atmospheric radar system for scientific research 8688 1SRI International announces findings from new upper atmospheric radar system for scientific research 8688 2SRI International announces findings from new upper atmospheric radar system for scientific research 8688 3SRI International announces findings from new upper atmospheric radar system for scientific research 8688 4National Partnership to Meet Evaluate Addiction Treatment as Component of New Justice Programs 47608 1National Partnership to Meet Evaluate Addiction Treatment as Component of New Justice Programs 47608 2National Partnership to Meet Evaluate Addiction Treatment as Component of New Justice Programs 47608 3
...MP4 and BMP7 inhibit the,growth of medulloblastoma...,into normal neurons, a finding that may lead to b...March 14 A discovery by St.,Jude Children,s Resea...eat,medulloblastoma, a rare but often fatal childh...rain,s signaling pathways inhibits the growth of t...
...maceuticals,Inc. today announced that enrollment h...ts that evaluates the safety and efficacy of its l...umatoid arthritis (RA). MM-093 is a,recombinant ve...omized, double-blind, placebo-controlled, Phase 2 ...the United States. The objective,of this study is ...
Other Medicine Technology:St. Jude Finds Signaling System That Halts the Growth of a Childhood Brain Cancer 2Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis 2
Clinical Xpert™ PDA Medical Reference and Decision-Support Tool
Diagnosoft HARP Cardiac MRI Tagging
VISULAS YAG III Combi Complete Laser Therapy System
...olter Monitoring System, equipped with the latest ...lysis algorithm, Heart Rate Variability analysis a...s with an Epicardia System in place have complete ...suit their needs, and managing their data. The Epi...
Medicine Products: